Adaptive Biotechnologies (ADPT) Inventory Average (2019 - 2026)

Adaptive Biotechnologies has disclosed Inventory Average across 8 years of filings, most recently posting $10.9 million for Q2 2026.

• In Q2 2026, Inventory Average rose 27.01% year-over-year to $10.9 million; the TTM figure through Jun 2026 stood at $10.9 million (up 27.01% YoY), while the FY2025 annual figure was $9.1 million, down 20.22% from the prior year.
• Inventory Average came in at $10.9 million for Q2 2026 at Adaptive Biotechnologies, up from $10.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $20.1 million in Q1 2022 to a low of $8.5 million in Q2 2025.
• Average Inventory Average over 5 years is $14.1 million, with a median of $13.6 million recorded in 2024.
• Year-over-year, Inventory Average grew 27.89% in 2022 and tumbled 39.91% in 2024.
• Over 5 years, Inventory Average stood at $15.9 million in 2022, then increased by 6.73% to $17.0 million in 2023, then plunged by 39.91% to $10.2 million in 2024, then retreated by 3.15% to $9.9 million in 2025, then grew by 9.87% to $10.9 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $10.9 million in Q2 2026, $10.5 million in Q1 2026, and $9.9 million in Q4 2025.